1
Country: USA | Funding: $53.9M
Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. We aim to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions.
Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. We aim to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions.
2
Country: Singapore | Funding: $24.8M
ABM Respiratory Care is a medical device startup that develops ventilation solutions for people suffering from pulmonary diseases.
ABM Respiratory Care is a medical device startup that develops ventilation solutions for people suffering from pulmonary diseases.
3
Country: Israel | Funding: $100k
Safe Shower invented a unique shower head, that minimizes the risk of Legionnaires' disease from sources of shower heads, by continuous disinfection in the shower head when the water stopped, with a small sized disinfection unit.
Safe Shower invented a unique shower head, that minimizes the risk of Legionnaires' disease from sources of shower heads, by continuous disinfection in the shower head when the water stopped, with a small sized disinfection unit.
4
Country: Sweden | Funding: €71.4K
Double Bond Pharmaceutical has developed ways to treat these brain cancer, liver cancer and pneumonia much more effectively with its drug delivery system.
Double Bond Pharmaceutical has developed ways to treat these brain cancer, liver cancer and pneumonia much more effectively with its drug delivery system.
